Please sign in to follow a disease.

Severe community-acquired pneum

Clinical trials for Severe community-acquired pneum explained in plain language.

Never miss a new study

Get alerted when new Severe community-acquired pneum trials appear

Sign up with your email to follow new studies for Severe community-acquired pneum, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

Immune boosting study for severe pneumonia pulled before start

Disease control Cancelled

This study was designed to see if adding two immune treatments (NAI and iNKT cells) to standard care could help critically ill adults with severe pneumonia, sepsis, or lung failure recover. It planned to enroll ICU patients and follow them for 90 days. However, the study was with…

Matched conditions: SEVERE COMMUNITY-ACQUIRED PNEUM

Phase 2 • Sponsor: ImmunityBio, Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:30 UTC

Severe community-acquired pneum

Get alerted when new Severe community-acquired pneum trials appear

Immune boosting study for severe pneumonia pulled before start